Related Experiment Videos

JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells

S G Rane1, E P Reddy

  • 1Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140.

Oncogene
|August 1, 1994
PubMed

Insights

Researchers discovered JAK3, a new Janus Kinase (JAK) family member, crucial for hematopoietic cell differentiation. This finding clarifies cytokine signal transduction pathways.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Hematopoiesis

Background:

  • Janus Kinases (JAK1, JAK2, TYK2) mediate cytokine signal transduction, influencing gene expression.
  • Cytokines like Granulocyte Colony Stimulating Factor (GCSF) can signal for both proliferation and differentiation.
  • The precise JAK kinase family members involved in these distinct signals remain unclear.

Purpose of the Study:

  • To identify novel members of the JAK kinase family.
  • To investigate the role of newly identified JAK kinases in cellular processes.

Main Methods:

  • Utilized a polymerase chain reaction (PCR) based strategy to discover new JAK family members.
  • Performed nucleotide sequence analysis of a full-length cDNA for the identified kinase.
  • Conducted expression studies in hematopoietic cells.

Main Results:

  • Identified a new JAK kinase family member, designated JAK3, encoded by a 4.3 kb mRNA.
  • JAK3 possesses a double catalytic domain characteristic of JAK kinases, with unique amino acid insertions.
  • JAK3 expression is low in immature hematopoietic cells but significantly increases during terminal differentiation.

Conclusions:

  • JAK3 is a novel member of the Janus Kinase family.
  • The unique structure of JAK3 suggests specialized functions within the JAK-STAT pathway.
  • JAK3 plays a critical role in the terminal differentiation of hematopoietic cells.

Related Concept Videos